Patents by Inventor John Posner

John Posner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of HPPD Inhibitors in the Treatment of Depression and/or Withdrawal Symptoms Associated with Addictive Drugs
    Publication number: 20100305095
    Abstract: The present invention relates to, inter alia, the use of a compound capable of inhibiting 4-hydroxyphenylpyruvate dioxygenase (HPPD) in an animal in the manufacture of a medicament for use in the treatment and/or prevention of depression. The invention also provides for the use of a compound capable of inhibiting HPPD in an animal in the manufacture of a medicament for use in the treatment of the withdrawal symptoms associated with an addictive drug which causes dopamine dependant associative learning disorders in said animal. In a particular embodiment said HPPD inhibitor is selected from the group consisting of the compound depicted as compound 1; 2; and 3.22.
    Type: Application
    Filed: August 18, 2006
    Publication date: December 2, 2010
    Inventors: Kim Zachary Travis, John Posner
  • Use of 1-(.beta.-D-arabinofuranosyl) -5-propynyluracil for lowering serum cholesterol
    Patent number: 5432166
    Abstract: The use of 1-(.beta.-D-arabinofuranosyl)-5-propynyluracil or a pharmaceutically acceptable salt or physiologically labile ester thereof for lowering serum cholesterol, particularly low density lipoprotein cholesterol levels in a human subject.
    Type: Grant
    Filed: February 11, 1993
    Date of Patent: July 11, 1995
    Assignee: Burroughs Wellcome Co.
    Inventors: Richard W. Peck, John Posner, Kenneth Powell